These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6956734)

  • 41. Methods for induced abortion.
    Stubblefield PG; Carr-Ellis S; Borgatta L
    Obstet Gynecol; 2004 Jul; 104(1):174-85. PubMed ID: 15229018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laparoscopic sterilization combined with dilation and evacuation up to 18 weeks' gestation.
    Kaali SG; Szigetvari I; Bartfai G; Feinman M
    J Reprod Med; 1989 Jul; 34(7):463-4. PubMed ID: 2527988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abortion complications and their management.
    Mccarthy T
    Singapore Fam Physician; 1981; 7(3):77-9. PubMed ID: 12266627
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaginally administered 16, 16-dimethyl-prostaglandin E2 as an agent for pre-operative cervical dilatation.
    Leader A; Bygdeman M; Gréen K; Martin JN; Wiqvist N
    Prostaglandins; 1975 Aug; 10(2):357-64. PubMed ID: 1178913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparative study of the efficacy and safety of synthetic prostaglandin E2 derivative and 15-methyl prostaglandin F2 alpha in the termination of midtrimester pregnancy.
    Biswas A; Roy S
    J Indian Med Assoc; 1996 Aug; 94(8):292-3. PubMed ID: 8855576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of endocervical administration of prostaglandin E2 on cervical dilatation and connective tissue biosynthesis in the first trimester of pregnancy.
    Norström A
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():461-4. PubMed ID: 6221632
    [No Abstract]   [Full Text] [Related]  

  • 47. [Use of prostaglandin E2 for induced abortion].
    Halle H; Lau HU; Hengst P
    Dtsch Gesundheitsw; 1975 Mar; 30(12):544-7. PubMed ID: 1126279
    [No Abstract]   [Full Text] [Related]  

  • 48. Midtrimester abortion.
    Hern WM
    Obstet Gynecol Annu; 1981; 10():375-422. PubMed ID: 7024878
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The termination of human pregnancy with prostaglandin analogs.
    Gutknecht GD; Southern EM
    J Reprod Med; 1975 Sep; 15(3):93-6. PubMed ID: 1214255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new abortion technique: intravaginal and intramuscular prostaglandin.
    Lauersen NH; Den T; Scher J; Iliescu C; Wilson KH
    Obstet Gynecol; 1981 Jul; 58(1):96-100. PubMed ID: 7243150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Acute complications of abortion].
    Obel E
    Ugeskr Laeger; 1976 Feb; 138(6):319-23. PubMed ID: 1251502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Induced abortion after the 12th week of pregnancy. I].
    Treffers PE; Blacquière JF
    Ned Tijdschr Geneeskd; 1979 Jun; 123(26):1103-10. PubMed ID: 460460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Termination of pregnancy in patients with previous cesarean section.
    Mazouni C; Provensal M; Porcu G; Guidicelli B; Heckenroth H; Gamerre M; Bretelle F
    Contraception; 2006 Mar; 73(3):244-8. PubMed ID: 16472563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of vaginal prostaglandin-E2 suppositories in septic abortion.
    Milano CT; Gleicher N
    Prostaglandins; 1980 Mar; 19(3):455-6. PubMed ID: 7384552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaginally administered 16, 16-dimethyl-PGE2 for the induction of midtrimester abortion.
    Martin JN; Bygdeman M; Ramadan M; Gréen K; Leader A; Lundström V; Wiqvist N
    Prostaglandins; 1976 Jan; 11(1):123-32. PubMed ID: 769088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical comparison of abortifacient activity of vaginally administered prostaglandin E2 in two dosage forms.
    Roseman TJ; Gutknecht GD; Stehle RG; Southern EM
    Am J Obstet Gynecol; 1977 Sep; 129(2):225-7. PubMed ID: 19973
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The management of midtrimester abortion failures by vaginal evacuation.
    Burkman RT; Atienza MF; King TM; Burnett LS
    Obstet Gynecol; 1977 Feb; 49(2):233-6. PubMed ID: 834407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostaglandin E2 vaginal suppositories in pregnancy with an anencephalic fetus.
    Boehm FH; Killam AP; Chambers JF; Davidson KK
    Obstet Gynecol; 1980 Jun; 55(6):758-60. PubMed ID: 7383465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Postconception menses induction using prostaglandin vaginal suppositories.
    Foster HW; Smith M; McGruder CE; Richard F; McIntyre J
    Obstet Gynecol; 1985 May; 65(5):682-5. PubMed ID: 3982746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deaths from second trimester abortion by dilatation and evacuation: causes, prevention, facilities.
    Cates W; Grimes DA
    Obstet Gynecol; 1981 Oct; 58(4):401-8. PubMed ID: 7279335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.